Orchard Therapeutics plc

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$38.4M

154 transactions

Summary

Orchard Therapeutics plc is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $23.6MSales: $14.7M14 insiders

Date	Insider	Type	Value
2024-01-24	Curnutte John T	D	$0
2024-01-24	Curnutte John T	D	$0
2024-01-24	Altschuler Steven	D	$0
2024-01-24	Altschuler Steven	D	$0
2024-01-24	Dunoyer Marc	D	$0
2024-01-24	Dunoyer Marc	D	$0
2024-01-24	Dunoyer Marc	D	$0
2024-01-24	Dunoyer Marc	D	—
2024-01-24	Gaspar Bobby(Chief Executive Officer)	D	$0
2024-01-24	Gaspar Bobby(Chief Executive Officer)	D	$0
2024-01-24	Gaspar Bobby(Chief Executive Officer)	D	$0
2024-01-24	Gaspar Bobby(Chief Executive Officer)	D	$0
2024-01-24	Gaspar Bobby(Chief Executive Officer)	D	$0
2024-01-24	Gaspar Bobby(Chief Executive Officer)	D	$0
2024-01-24	Gaspar Bobby(Chief Executive Officer)	D	$0
2024-01-24	Gaspar Bobby(Chief Executive Officer)	D	$0
2024-01-24	Gaspar Bobby(Chief Executive Officer)	D	$0
2024-01-24	Gaspar Bobby(Chief Executive Officer)	D	$0
2024-01-24	Gaspar Bobby(Chief Executive Officer)	D	$0
2024-01-24	Gaspar Bobby(Chief Executive Officer)	D	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Orchard Therapeutics plc — Contributions, Lobbying & Contracts | Poliscope